During the 72-month (range: 6–228months) follow-up period, six patients were diagnosed with NMOSD (Figure 2), including one with ADEM onset and recurring AQP4-positive patients who was subsequently categorized as NMOSD. This evidence concerns the gene AQP4 and acute disseminated encephalomyelitis.